Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$75.49 - $124.16 $4.97 Million - $8.17 Million
-65,779 Reduced 90.05%
7,265 $902,000
Q3 2023

Nov 14, 2023

BUY
$86.06 - $137.93 $1 Million - $1.61 Million
11,668 Added 19.01%
73,044 $6.82 Million
Q2 2023

Aug 14, 2023

BUY
$112.47 - $130.98 $4.46 Million - $5.19 Million
39,618 Added 182.08%
61,376 $7.89 Million
Q1 2023

May 15, 2023

SELL
$104.0 - $122.92 $1.54 Million - $1.82 Million
-14,785 Reduced 40.46%
21,758 $2.53 Million
Q4 2022

Feb 14, 2023

SELL
$84.98 - $122.67 $4.58 Million - $6.62 Million
-53,948 Reduced 59.62%
36,543 $4.14 Million
Q3 2022

Nov 14, 2022

BUY
$76.35 - $94.18 $4.18 Million - $5.16 Million
54,810 Added 153.61%
90,491 $7.29 Million
Q2 2022

Aug 15, 2022

BUY
$67.99 - $132.89 $1.07 Million - $2.1 Million
15,785 Added 79.34%
35,681 $2.66 Million
Q1 2022

May 16, 2022

BUY
$94.08 - $130.2 $742,855 - $1.03 Million
7,896 Added 65.8%
19,896 $10.2 Million
Q4 2021

Feb 14, 2022

BUY
$129.87 - $162.82 $46,103 - $57,801
355 Added 3.05%
12,000 $6.44 Million
Q3 2021

Nov 15, 2021

SELL
$106.71 - $143.18 $110,338 - $148,048
-1,034 Reduced 8.16%
11,645 $6.37 Million
Q2 2021

Aug 16, 2021

BUY
$80.99 - $107.93 $11,257 - $15,002
139 Added 1.11%
12,679 $5.41 Million
Q1 2021

May 14, 2021

SELL
$84.79 - $104.74 $293,373 - $362,400
-3,460 Reduced 21.63%
12,540 $4.51 Million
Q4 2020

Feb 16, 2021

SELL
$78.0 - $104.5 $392,964 - $526,471
-5,038 Reduced 23.95%
16,000 $5.92 Million
Q3 2020

Nov 16, 2020

SELL
$95.51 - $112.95 $344,886 - $407,862
-3,611 Reduced 14.65%
21,038 $8.67 Million
Q2 2020

Aug 14, 2020

BUY
$62.68 - $105.34 $166,039 - $279,045
2,649 Added 12.04%
24,649 $9.99 Million
Q1 2020

May 15, 2020

BUY
$47.79 - $75.63 $23,895 - $37,815
500 Added 2.33%
22,000 $5.92 Million
Q4 2019

Feb 14, 2020

SELL
$36.62 - $57.29 $311,270 - $486,965
-8,500 Reduced 28.33%
21,500 $4.7 Million
Q3 2019

Nov 14, 2019

SELL
$35.53 - $43.8 $529,397 - $652,620
-14,900 Reduced 33.18%
30,000 $4.48 Million
Q2 2019

Aug 14, 2019

SELL
$27.84 - $38.92 $75,168 - $105,084
-2,700 Reduced 5.67%
44,900 $6.73 Million
Q1 2019

May 15, 2019

BUY
$28.07 - $38.18 $16,842 - $22,908
600 Added 1.28%
47,600 $5.67 Million
Q4 2018

Feb 14, 2019

BUY
$26.99 - $37.37 $229,415 - $317,645
8,500 Added 22.08%
47,000 $5.63 Million
Q3 2018

Nov 14, 2018

SELL
$23.35 - $36.72 $151,775 - $238,680
-6,500 Reduced 14.44%
38,500 $5.51 Million
Q2 2018

Aug 14, 2018

SELL
$17.54 - $25.22 $87,700 - $126,100
-5,000 Reduced 10.0%
45,000 $4.27 Million
Q1 2018

May 15, 2018

SELL
$13.06 - $18.54 $261,200 - $370,800
-20,000 Reduced 28.57%
50,000 $3.71 Million
Q4 2017

Feb 14, 2018

BUY
$11.12 - $15.38 $55,599 - $76,900
5,000 Added 7.69%
70,000 $4.02 Million
Q3 2017

Nov 14, 2017

BUY
$11.36 - $18.98 $738,400 - $1.23 Million
65,000
65,000 $3.18 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.